For citations:
Bessmeltsev S.S., Stelmashenko L.V., Podoltseva E.I., Kariagina E.V., Salogub G.N., Nisamutdinova А.S., Matuhina L.M., Abdulkadyrov K.M. Bortezomib (Velcade) in combination with dexamethasone eor relapsed or refractory myeloma. Oncohematology. 2007;(4):61-66. (In Russ.) https://doi.org/10.17650/1818-8346-2007-0-4-61-66
Email this article 